In vitro assessment of the postantibiotic effect of lomefloxacin against gram-positive and gram-negative pathogens

The American Journal of Medicine

Volumn 92, Issue 4 SUPPL. 1, 1992, Pages

  Debbia, Eugenio A ^a   Pesce, Adelaide ^a   Schito, Gian Carlo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; LOMEFLOXACIN; OFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; DOSE TIME EFFECT RELATION; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-INFECTIVE AGENTS, QUINOLONE; CIPROFLOXACIN; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; QUINOLONES; TIME FACTORS;

EID: 0026544819     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(92)90308-X     Document Type: Article

References (11)

1. The postantibiotic effect
2. Postantibiotic suppression of bacterial growth
3. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time
4. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria
5. In vivo post-antibiotic effect in a thigh infection in neutropenic mice
6. In vitro activity of lomefloxacin, a new quinolone antimicrobial agents, in comparison with those of other agents
7. In vitro activity of lomefloxacin (SC-47111: NY-198), a difluoroquinolone 3-carboxylic acid, compared to those of other quinolones
8. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses
9. Pharmacokinetics and tissue penetration of orally administered lomefloxacin
10. In vitro activity of LY146032 alone and in combination with other antibiotics against gram-positive bacteria
11. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model